NCT05324423

To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout

A Single-center, Open-access Study to Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: The Affiliated Hospital of Qingdao University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

A single-center, open-access study to evaluate drug interactions between XNW3009, febuxostat, and colchicine in patients with gout

Conditions

• Gout

Interventions

Type	Name	Description
DRUG	Colchicine	Colchicine0.5 mg Oral Tablet Day-7\~Day25 qd；Febuxostat 40 mg Oral Tablet Day1 and Day14 qd；XNW3009 0.5 mg Oral Tablet Day8 and Day21 qd

Timeline

• Start date: 2021-10-18
• Primary completion: 2022-08-01
• Completion: 2022-09-01
• First posted: 2022-04-12
• Last updated: 2022-05-09

Locations

1 site across 1 country: China